NOVEL USE OF COMPOUNDS AND COMBINATIONS OF COMPOUNDS FOR IMPROVING THE PHYSICAL APPEARANCE
    3.
    发明申请
    NOVEL USE OF COMPOUNDS AND COMBINATIONS OF COMPOUNDS FOR IMPROVING THE PHYSICAL APPEARANCE 审中-公开
    化合物的新用途和化合物的组合改善物理外观

    公开(公告)号:US20100015262A1

    公开(公告)日:2010-01-21

    申请号:US12295408

    申请日:2007-04-02

    摘要: The present invention is directed inter alia to the use of at least one compound selected from the group consisting of (−)-epigallocatechin gallate, resveratrol, eicosapentaenoic acid, docosahexaenioic acid, rose hip extract/concentrate, hydroxytyrosol, lycopene, lutein, β-cryptoxanthin, zeaxanithin and derivatives thereof, for the treatment of cellulite, for the prevention of the development of mild cellulite, for the prevention of the progression of mild cellulite to severe cellulite, for smoothening the micro relief of the skin, for maintaining or increasing the tensile properties of the skin, and/or for reducing the fat mass and the circumference at the hips and thighs, as well as to the corresponding cosmetic and medical methods.

    摘要翻译: 本发明特别涉及使用至少一种选自( - ) - 表没食子儿茶素没食子酸酯,白藜芦醇,二十碳五烯酸,二十二碳六烯酸,玫瑰果提取物/浓缩物,羟基酪醇,番茄红素,叶黄素,β- 隐黄质,玉米黄素及其衍生物,用于治疗脂肪团,用于防止轻度脂肪团的发育,用于防止轻度脂肪团进入严重脂肪团的进展,以平滑皮肤的微小浮雕,维持或增加 皮肤的拉伸性能和/或用于降低臀部和大腿处的脂肪量和周长,以及相应的美容和医疗方法。

    NOVEL COMPOSITIONS
    5.
    发明申请
    NOVEL COMPOSITIONS 有权
    新组合

    公开(公告)号:US20100056463A1

    公开(公告)日:2010-03-04

    申请号:US12373584

    申请日:2007-07-12

    IPC分类号: A61K31/7004 A61K31/05

    摘要: The present invention relates to novel compositions comprising hydroxytyrosol and/or oleuropein (I) and at least one additional component e.g. selected from the group of ligustilide, oleuropein aglycone, magnolol, honokiol, genistein, resveratrol, EGCG, magnolia bark extract, cashew fruit extract and Glycyrrhiza foetida as well as to the use of these compositions as a medicament, in particular as a medicament for the treatment, co-treatment or prevention of inflammatory disorders.

    摘要翻译: 本发明涉及包含羟基酪醇和/或橄榄苦蛋白(I)和至少一种另外的组分的新型组合物, 选自ligustilide,橄榄苦苷苷,厚朴酚,和厚朴酚,染料木素,白藜芦醇,EGCG,木兰树皮提取物,腰果提取物和甘草,以及这些组合物作为药物的用途,特别是作为药物的用途 治疗,共同治疗或预防炎症性疾病。